• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

治疗性蛋白修饰的统计特征。

Statistical characterization of therapeutic protein modifications.

机构信息

Northeastern University, 360 Huntington Avenue, Boston, MA, 02115, USA.

Protein Analytical Chemistry, Genentech, 1 DNA Way, South San Francisco, CA, 94080, USA.

出版信息

Sci Rep. 2017 Aug 11;7(1):7896. doi: 10.1038/s41598-017-08333-y.

DOI:10.1038/s41598-017-08333-y
PMID:28801661
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5554216/
Abstract

Peptide mapping with liquid chromatography-tandem mass spectrometry (LC-MS/MS) is an important analytical method for characterization of post-translational and chemical modifications in therapeutic proteins. Despite its importance, there is currently no consensus on the statistical analysis of the resulting data. In this manuscript, we distinguish three statistical goals for therapeutic protein characterization: (1) estimation of site occupancy of modifications in one condition, (2) detection of differential site occupancy between conditions, and (3) estimation of combined site occupancy across multiple modification sites. We propose an approach, which addresses these goals in terms of summarizing the quantitative information from the mass spectra, statistical modeling, and model-based analysis of LC-MS/MS data. We illustrate the approach using an LC-MS/MS experiment from an antibody-drug conjugate and its monoclonal antibody intermediate. The performance was compared to a 'naïve' data analysis approach, by using computer simulation, evaluation of differential site occupancy in positive and negative controls, and comparisons of estimated site occupancy with orthogonal experimental measurements of N-linked glycoforms and total oxidation. The results demonstrated the importance of replicated studies of protein characterization, and of appropriate statistical modeling, for reproducible, accurate and efficient site occupancy estimation and differential analysis.

摘要

肽图分析与液相色谱-串联质谱(LC-MS/MS)联用是一种用于鉴定治疗性蛋白翻译后修饰和化学修饰的重要分析方法。尽管其重要性不言而喻,但目前对于该类数据的统计分析尚无共识。在本文中,我们将治疗性蛋白的特征描述分为三个统计学目标:(1)在一个条件下估计修饰的位点占有率,(2)检测不同条件下的修饰的位点占有率差异,以及(3)跨多个修饰位点估计修饰的位点占有率的综合值。我们提出了一种方法,该方法通过对质谱的定量信息进行总结、统计建模和基于模型的 LC-MS/MS 数据分析来实现这些目标。我们使用抗体药物偶联物及其单克隆抗体中间物的 LC-MS/MS 实验对该方法进行了说明。通过计算机模拟、阳性和阴性对照中差异修饰的位点占有率评估以及与 N-连接糖型和总氧化的正交实验测量结果的修饰的位点占有率估计值的比较,我们将该方法的性能与“原始”数据分析方法进行了比较。结果表明,对于治疗性蛋白的特征描述重复性研究以及适当的统计建模对于重现性、准确性和高效的修饰的位点占有率估计和差异分析非常重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c8d/5554216/5f1f99e6cd43/41598_2017_8333_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c8d/5554216/0e4fcde185b0/41598_2017_8333_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c8d/5554216/a72a300e9e6c/41598_2017_8333_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c8d/5554216/86b4f01b3735/41598_2017_8333_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c8d/5554216/6602f8d5d490/41598_2017_8333_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c8d/5554216/0796ca5abfcd/41598_2017_8333_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c8d/5554216/5f1f99e6cd43/41598_2017_8333_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c8d/5554216/0e4fcde185b0/41598_2017_8333_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c8d/5554216/a72a300e9e6c/41598_2017_8333_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c8d/5554216/86b4f01b3735/41598_2017_8333_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c8d/5554216/6602f8d5d490/41598_2017_8333_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c8d/5554216/0796ca5abfcd/41598_2017_8333_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c8d/5554216/5f1f99e6cd43/41598_2017_8333_Fig7_HTML.jpg

相似文献

1
Statistical characterization of therapeutic protein modifications.治疗性蛋白修饰的统计特征。
Sci Rep. 2017 Aug 11;7(1):7896. doi: 10.1038/s41598-017-08333-y.
2
Characterization of protein impurities and site-specific modifications using peptide mapping with liquid chromatography and data independent acquisition mass spectrometry.使用液相色谱肽图分析和数据非依赖型采集质谱法对蛋白质杂质和位点特异性修饰进行表征。
Anal Chem. 2009 Jul 15;81(14):5699-708. doi: 10.1021/ac900468j.
3
Characterization of glycosylation sites for a recombinant IgG1 monoclonal antibody and a CTLA4-Ig fusion protein by liquid chromatography-mass spectrometry peptide mapping.用液相色谱-质谱肽图法分析重组 IgG1 单克隆抗体和 CTLA4-Ig 融合蛋白的糖基化位点。
J Chromatogr A. 2011 Nov 11;1218(45):8140-9. doi: 10.1016/j.chroma.2011.08.089. Epub 2011 Sep 3.
4
Qualification of a Quantitative Method for Monitoring Aspartate Isomerization of a Monoclonal Antibody by Focused Peptide Mapping.通过聚焦肽图分析监测单克隆抗体天冬氨酸异构化定量方法的验证
PDA J Pharm Sci Technol. 2016;70(6):490-507. doi: 10.5731/pdajpst.2015.006239. Epub 2016 Apr 18.
5
Examination of segmental average mass spectra from liquid chromatography-tandem mass spectrometric (LC-MS/MS) data enables screening of multiple types of protein modifications.从液相色谱-串联质谱(LC-MS/MS)数据中检查分段平均质谱,可实现多种类型蛋白质修饰的筛选。
Anal Chim Acta. 2015 Sep 10;892:115-22. doi: 10.1016/j.aca.2015.07.032. Epub 2015 Aug 10.
6
Analysis of post-translational modifications by LC-MS/MS.通过液相色谱-串联质谱法分析翻译后修饰
Methods Mol Biol. 2010;658:93-108. doi: 10.1007/978-1-60761-780-8_5.
7
Direct Liquid Chromatography/Mass Spectrometry Analysis for Complete Characterization of Recombinant Adeno-Associated Virus Capsid Proteins.直接液相色谱/质谱分析法用于重组腺相关病毒衣壳蛋白的全面表征
Hum Gene Ther Methods. 2017 Oct;28(5):255-267. doi: 10.1089/hgtb.2016.178. Epub 2017 Jun 16.
8
Characterization of N-palmitoylated human growth hormone by in situ liquid-liquid extraction and MALDI tandem mass spectrometry.通过原位液-液萃取和基质辅助激光解吸电离串联质谱法对N-棕榈酰化人生长激素进行表征
J Mass Spectrom. 2007 Jun;42(6):724-34. doi: 10.1002/jms.1207.
9
LC-MS Differential Analysis for Fast and Sensitive Determination of Biotransformation of Therapeutic Proteins.LC-MS 差示分析用于快速灵敏地测定治疗性蛋白的生物转化。
Drug Metab Dispos. 2018 Apr;46(4):451-457. doi: 10.1124/dmd.117.077792. Epub 2018 Jan 31.
10
Orthogonal tools to help determine the required selectivity of ligand-binding assays in drug development.用于帮助确定药物开发中配体结合测定所需选择性的正交工具。
Bioanalysis. 2014 Apr;6(8):1037-40. doi: 10.4155/bio.14.47.

引用本文的文献

1
New Quality-Range-Setting Method Based on Between- and Within-Batch Variability for Biosimilarity Assessment.基于批次间和批次内变异性的生物相似性评估新质量范围设定方法
Pharmaceuticals (Basel). 2021 Jun 1;14(6):527. doi: 10.3390/ph14060527.
2
Systematic LC/MS/MS Investigations for the IND-Enabling Extended Characterization of Antibody-Drug Conjugate Modifications.用于支持IND的抗体药物偶联物修饰扩展表征的系统液相色谱-串联质谱研究
Antibodies (Basel). 2018 Nov 16;7(4):40. doi: 10.3390/antib7040040.

本文引用的文献

1
Totality of the evidence at work: The first U.S. biosimilar.工作中的全部证据:首个美国生物类似药。
Expert Opin Biol Ther. 2016;16(2):137-42. doi: 10.1517/14712598.2016.1128410. Epub 2015 Dec 23.
2
In vitro glycoengineering of IgG1 and its effect on Fc receptor binding and ADCC activity.IgG1的体外糖基工程及其对Fc受体结合和ADCC活性的影响。
PLoS One. 2015 Aug 12;10(8):e0134949. doi: 10.1371/journal.pone.0134949. eCollection 2015.
3
Fc glycans of therapeutic antibodies as critical quality attributes.治疗性抗体的Fc聚糖作为关键质量属性
Glycobiology. 2015 Dec;25(12):1325-34. doi: 10.1093/glycob/cwv065. Epub 2015 Aug 11.
4
Computational and statistical methods for high-throughput analysis of post-translational modifications of proteins.用于蛋白质翻译后修饰高通量分析的计算和统计方法。
J Proteomics. 2015 Nov 3;129:3-15. doi: 10.1016/j.jprot.2015.07.016. Epub 2015 Jul 26.
5
Development of a quantitative mass spectrometry multi-attribute method for characterization, quality control testing and disposition of biologics.开发一种用于生物制品表征、质量控制测试和处置的定量质谱多属性方法。
MAbs. 2015;7(5):881-90. doi: 10.1080/19420862.2015.1069454. Epub 2015 Jul 17.
6
Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles-Part 2: Mass spectrometric methods.治疗性免疫球蛋白G Fc糖基化谱分析方法的比较 - 第2部分:质谱方法
MAbs. 2015;7(4):732-42. doi: 10.1080/19420862.2015.1045173.
7
The therapeutic monoclonal antibody market.治疗性单克隆抗体市场。
MAbs. 2015;7(1):9-14. doi: 10.4161/19420862.2015.989042.
8
Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles--part 1: separation-based methods.治疗性免疫球蛋白G Fc糖基化谱分析方法的比较——第1部分:基于分离的方法。
MAbs. 2015;7(1):167-79. doi: 10.4161/19420862.2014.986000.
9
Antibodies to watch in 2015.2015年需关注的抗体。
MAbs. 2015;7(1):1-8. doi: 10.4161/19420862.2015.988944.
10
An overview of FDA-approved biologics medicines.美国食品药品监督管理局(FDA)批准的生物制品药物概述。
Drug Discov Today. 2015 Apr;20(4):393-8. doi: 10.1016/j.drudis.2014.09.003. Epub 2014 Sep 16.